Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/29/2014US20140148418 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
05/29/2014US20140148413 Compositions and methods for preventing and treating organ injury and/or dysfunction
05/29/2014US20140148409 Fluid for peritoneal dialysis
05/29/2014US20140148408 Antimicrobial Compositions
05/29/2014US20140148406 Hyaluronic acid based formulations
05/29/2014US20140148405 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha
05/29/2014US20140148404 Composition and uses of galectin antagonists
05/29/2014US20140148403 Novel Ticagrelor Co-Crystal
05/29/2014US20140148402 Diagnostic Assays and Methods of Treating Pneumonia, Sepsis and Systemic Inflammatory Response Syndrome
05/29/2014US20140148400 Carbonic anhydrase inhibitors with antimetastatic activity
05/29/2014US20140148399 Compositions and methods for treating or ameliorating obesity or for reducing diabetic hypercholesterolemia
05/29/2014US20140148398 Methods of treating giardiasis
05/29/2014US20140148383 Entacapone for prevention and treatment of obesity and related metabolic diseases
05/29/2014US20140147537 Fruit extracts
05/29/2014US20140147530 Treatment product with natural cellular dna care ingredient and functional component
05/29/2014US20140147529 Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
05/29/2014US20140147526 Antioxidant dietary supplement and related method
05/29/2014US20140147524 Truely Re'Vived
05/29/2014US20140147522 Gastric health supplement and methods thereof
05/29/2014US20140147520 Water-based Personal Moisturizers and Lubricants, in Particular Vaginal Lubricants, and Uses Thereof
05/29/2014US20140147519 Migraine Treatment
05/29/2014US20140147518 Solutions comprising polyethylene glycol and electrolytes
05/29/2014US20140147517 Use of Amisulpride as an Anti-Emetic
05/29/2014US20140147515 Methods And Compositions For Controlling Parasitic Infections Of Animals
05/29/2014US20140147514 Extraction of vitamins and minerals from plant matter
05/29/2014US20140147508 Nano-Carrier, Complex of Anticancer Drug and Nano-Carrier, Pharmaceutical Composition Thereof, Method for Manufacturing the Complex, and Method for Treating Cancer by Using the Pharmaceutical Composition
05/29/2014US20140147506 Delivery of Submicrometer and Nanometer Aerosols to the Lungs using Hygroscopic Excipients or Dual Stream Nasal Delivery
05/29/2014US20140147505 Solid pharmaceutical dosage form of ticagrelor
05/29/2014US20140147504 Tetracycline topical formulations, preparation and uses thereof
05/29/2014US20140147503 Pharmaceutical Composition Comprising Deferasirox
05/29/2014US20140147500 Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems
05/29/2014US20140147499 Abuse-proofed oral dosage form
05/29/2014US20140147498 Compositions containing coenzyme q-10 and dihydrolipoic acid
05/29/2014US20140147497 Pediatric formulation
05/29/2014US20140147496 Composition and method for fertility therapy using nutritional supplements
05/29/2014US20140147492 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
05/29/2014US20140147486 Implants for the treatment of dopamine associated states
05/29/2014US20140147485 Polymer for creating hemocompatible surface
05/29/2014US20140147484 Cell-Free Tissue Engineered Vascular Grafts
05/29/2014US20140147474 Pharmaceutical emulsion compositions comprising progestogen
05/29/2014US20140147472 Bioadhesive composition and device for repairing tissue damage
05/29/2014US20140147471 Immunostimulatory compositions and methods of use thereof
05/29/2014US20140147464 Method and composition for inducing autophagy
05/29/2014US20140147448 Novel compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
05/29/2014US20140147442 Use of il-23 antagonists for treatment of infection
05/29/2014US20140147441 Compositions containing alpha-1-antitrypsin and methods for use
05/29/2014US20140147440 Uses of nanog inhibitors and related methods
05/29/2014US20140147434 NCoR1 is a Physiological Modulator of Muscle Mass and Oxidative Function
05/29/2014US20140147433 Methods and devices suitable for improved reattachment of detached cartilage to subchondral bone
05/29/2014US20140147428 Neurodegenerative disorders and muscle diseases implicating pufas
05/29/2014US20140147424 Compositions to effect neuronal growth
05/29/2014US20140147415 Treatment of mastocytosis with masitinib
05/29/2014US20140147413 Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
05/29/2014US20140147411 Methods of treating cancer and testing mutation zygosity related thereto
05/29/2014US20140147401 Use of chitosans to increase nail growth rate
05/29/2014US20140147396 Compositions for the treatment of rosacea
05/29/2014US20140147393 Pharmaceutical Composition
05/29/2014US20140147386 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
05/29/2014US20140144442 Nasal administration
05/28/2014EP2735613A1 TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION
05/28/2014EP2735567A1 Heterocyclic substituted pyrimidine compound
05/28/2014EP2735562A1 Estrogen receptor modulators and uses thereof
05/28/2014EP2735561A1 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
05/28/2014EP2735338A1 Pharmaceutical combination of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and pregabalin or gabapentin
05/28/2014EP2735316A1 New therapeutic approaches for treating neuroinflammatory conditions
05/28/2014EP2735314A1 Improved sugar-coated liposome composition
05/28/2014EP2735312A1 Anti-glycation agent comprising a garcinia kola extract or fraction
05/28/2014EP2735310A1 Formulations of deoxycholic acid and salts thereof
05/28/2014EP2735309A1 Pharmaceutical composition for the treatment of calcific tendinitis and/or calcific bursitis
05/28/2014EP2735307A1 Compacted Moxifloxacin
05/28/2014EP2735306A1 Method for manufacturing a pharmaceutical composition in the form of extended-release tablets containing pirfenidone and use thereof in the regression of chronic renal insufficiency, breast capsular contracture and hepatic fibrosis in humans
05/28/2014EP2735305A1 Stabilised liquid pharmaceutical preparations
05/28/2014EP2734535A2 2',3'-DIDEOXY-2'-alpha-FLUORO-2'-beta-C-METHYLNUCLEOSIDES AND PRODRUGS THEREOF
05/28/2014EP2734534A1 Imino-sugar c-glycosides, preparation and use thereof
05/28/2014EP2734531A1 Phospholipid-detergent conjugates and uses thereof
05/28/2014EP2734530A1 Heterocyclic compounds and uses thereof
05/28/2014EP2734529A1 Btk inhibitors
05/28/2014EP2734526A1 Heterocyclic amide derivatives as p2x7 receptor antagonists
05/28/2014EP2734524A1 PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS, THEIR PREPARATION AND USE AS SIGMA LIGANDS
05/28/2014EP2734523A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors
05/28/2014EP2734522A1 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors
05/28/2014EP2734521A1 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
05/28/2014EP2734520A1 Heterocyclic compounds and uses thereof
05/28/2014EP2734519A1 Anti-biofilm compounds
05/28/2014EP2734517A1 Benzamides
05/28/2014EP2734516A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
05/28/2014EP2734515A1 Thiophen-2-carboxylic acid derivatives useful as inhibitors of flaviviridae viruses
05/28/2014EP2734510A2 Activators of class i histone deacetlyases (hdacs) and uses thereof
05/28/2014EP2734507A1 Process for the synthesis of n-substituted cyclic alkylene ureas
05/28/2014EP2734506A1 Process for the synthesis of cyclic alkylene ureas
05/28/2014EP2734505A1 3-(fluorvinyl)pyrazoles and the use thereof
05/28/2014EP2734504A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
05/28/2014EP2734503A1 Quinolinyl glucagon receptor modulators
05/28/2014EP2734497A1 Indane dimers for use in the treatment of autoimmune inflammatory disease
05/28/2014EP2734496A1 Indene derivatives for use in the treatment of inflammatory bowel disease
05/28/2014EP2734262A1 Intravaginal devices for drug delivery
05/28/2014EP2734240A2 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells
05/28/2014EP2734214A1 Targeted osmotic lysis of cancer cells
05/28/2014EP2734213A2 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
05/28/2014EP2734212A1 Methods of treating pain
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 7860